Prognostic value of lymph node evaluation in small bowel adenocarcinoma: Analysis of the surveillance, epidemiology, and end results database

Cancer

Volumn 116, Issue 23, 2010, Pages 5374-5382

  Overman, Michael J ^a   Hu, Chung Yuan ^a   Wolff, Robert A ^a   Chang, George J ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

adenocarcinoma; curative resection; lymph nodes; prognosis; small bowel; small intestine

Indexed keywords

ADENOCARCINOMA; ADULT; AGED; ARTICLE; CANCER GRADING; CANCER LOCALIZATION; CANCER REGISTRY; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; DISEASE FREE SURVIVAL; FEMALE; HISTOPATHOLOGY; HUMAN; INTESTINE SURGERY; LYMPH NODE; MAJOR CLINICAL STUDY; MALE; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; SMALL INTESTINE CARCINOMA; SURVIVAL TIME; TUMOR CLASSIFICATION;

ADENOCARCINOMA; AGED; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; INTESTINAL NEOPLASMS; INTESTINE, SMALL; LYMPH NODES; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; SEER PROGRAM; TREATMENT OUTCOME;

EID: 78649613793     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.25324     Document Type: Article

References (33)

1. Bilimoria KY, Bentrem DJ, Wayne JD, Ko CY, Bennett CL, Talamonti MS,. Small bowel cancer in the United States: changes in epidemiology, treatment, and survival over the last 20 years. Ann Surg. 2009; 249: 63-71.
2. Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2008. CA Cancer J Clin. 2008; 58: 71-96.
3. Abrahams NA, Halverson A, Fazio VW, Rybicki LA, Goldblum JR,. Adenocarcinoma of the small bowel: a study of 37 cases with emphasis on histologic prognostic factors. Dis Colon Rectum. 2002; 45: 1496-1502.
4. Bakaeen FG, Murr MM, Sarr MG, et al. What prognostic factors are important in duodenal adenocarcinoma? Arch Surg. 2000; 135: 635-641; discussion 641-642.
5. Bauer RL, Palmer ML, Bauer AM, Nava HR, Douglass HO Jr,. Adenocarcinoma of the small intestine: 21-year review of diagnosis, treatment, and prognosis. Ann Surg Oncol. 1994; 1: 183-188.
6. Brucher BL, Stein HJ, Roder JD, et al. New aspects of prognostic factors in adenocarcinomas of the small bowel. Hepatogastroenterology. 2001; 48: 727-732.
7. Kaklamanos IG, Bathe OF, Franceschi D, Camarda C, Levi J, Livingstone AS,. Extent of resection in the management of duodenal adenocarcinoma. Am J Surg. 2000; 179: 37-41.
8. Ouriel K, Adams JT,. Adenocarcinoma of the small intestine. Am J Surg. 1984; 147: 66-71.
9. Wu TJ, Yeh CN, Chao TC, Jan YY, Chen MF,. Prognostic factors of primary small bowel adenocarcinoma: univariate and multivariate analysis. World J Surg. 2006; 30: 391-398; discussion 399.
10. Altorki NK, Zhou XK, Stiles B, et al. Total number of resected lymph nodes predicts survival in esophageal cancer. Ann Surg. 2008; 248: 221-226.
11. Hellan M, Sun CL, Artinyan A, et al. The impact of lymph node number on survival in patients with lymph node-negative pancreatic cancer. Pancreas. 2008; 37: 19-24.
12. Le Voyer TE, Sigurdson ER, Hanlon AL, et al. Colon cancer survival is associated with increasing number of lymph nodes analyzed: a secondary survey of Intergroup Trial INT-0089. J Clin Oncol. 2003; 21: 2912-2919.
13. Smith DD, Schwarz RR, Schwarz RE,. Impact of total lymph node count on staging and survival after gastrectomy for gastric cancer: data from a large US-population database. J Clin Oncol. 2005; 23: 7114-7124.
14. Benson AB 3rd, Schrag D, Somerfield MR, et al. American Society of Clinical Oncology recommendations on adjuvant chemotherapy for stage II colon cancer. J Clin Oncol. 2004; 22: 3408-3419.
15. Chang GJ, Rodriguez-Bigas MA, Skibber JM, Moyer VA,. Lymph node evaluation and survival after curative resection of colon cancer: systematic review. J Natl Cancer Inst. 2007; 99: 433-441.
16. Greene FL, Page DL, Fleming ID, et al, eds. AJCC Cancer Staging Handbook, 6th ed. New York: Springer Verlag; 2002.
17. Howe JR, Karnell LH, Menck HR, Scott-Conner C,. The American College of Surgeons Commission on Cancer and the American Cancer Society. Adenocarcinoma of the small bowel: review of the National Cancer Data Base, 1985-1995. Cancer. 1999; 86: 2693-2706.
18. Goldstein NS,. Lymph node recoveries from 2427 pT3 colorectal resection specimens spanning 45 years: recommendations for a minimum number of recovered lymph nodes based on predictive probabilities. Am J Surg Pathol. 2002; 26: 179-189.
19. Wong JH, Bowles BJ, Bueno R, Shimizu D,. Impact of the number of negative nodes on disease-free survival in colorectal cancer patients. Dis Colon Rectum. 2002; 45: 1341-1348.
20. Baxter NN, Virnig DJ, Rothenberger DA, Morris AM, Jessurun J, Virnig BA,. Lymph node evaluation in colorectal cancer patients: a population-based study. J Natl Cancer Inst. 2005; 97: 219-225.
21. Gorog D, Nagy P, Peter A, Perner F,. Influence of obesity on lymph node recovery from rectal resection specimens. Pathol Oncol Res. 2003; 9: 180-183.
22. Wright FC, Law CH, Last L, et al. Lymph node retrieval and assessment in stage II colorectal cancer: a population-based study. Ann Surg Oncol. 2003; 10: 903-909.
23. Harmon JW, Tang DG, Gordon TA, et al. Hospital volume can serve as a surrogate for surgeon volume for achieving excellent outcomes in colorectal resection. Ann Surg. 1999; 230: 404-411; discussion 411-413.
24. Ko CY, Chang JT, Chaudhry S, Kominski G,. Are high-volume surgeons and hospitals the most important predictors of in-hospital outcome for colon cancer resection? Surgery. 2002; 132: 268-273.
25. Miller EA, Woosley J, Martin CF, Sandler RS,. Hospital-to-hospital variation in lymph node detection after colorectal resection. Cancer. 2004; 101: 1065-1071.
26. Panageas KS, Schrag D, Riedel E, Bach PB, Begg CB,. The effect of clustering of outcomes on the association of procedure volume and surgical outcomes. Ann Intern Med. 2003; 139: 658-665.
27. Vinh-Hung V, Verkooijen HM, Fioretta G, et al. Lymph node ratio as an alternative to pN staging in node-positive breast cancer. J Clin Oncol. 2009; 27: 1062-1068.
28. Inoue K, Nakane Y, Iiyama H, et al. The superiority of ratio-based lymph node staging in gastric carcinoma. Ann Surg Oncol. 2002; 9: 27-34.
29. Wang J, Hassett JM, Dayton MT, Kulaylat MN,. Lymph node ratio: role in the staging of node-positive colon cancer. Ann Surg Oncol. 2008; 15: 1600-1608.
30. Agrawal S, McCarron EC, Gibbs JF, Nava HR, Wilding GE, Rajput A,. Surgical management and outcome in primary adenocarcinoma of the small bowel. Ann Surg Oncol. 2007; 14: 2263-2269.
31. Dabaja BS, Suki D, Pro B, Bonnen M, Ajani J,. Adenocarcinoma of the small bowel: presentation, prognostic factors, and outcome of 217 patients. Cancer. 2004; 101: 518-526.
32. Fishman PN, Pond GR, Moore MJ, et al. Natural history and chemotherapy effectiveness for advanced adenocarcinoma of the small bowel: a retrospective review of 113 cases. Am J Clin Oncol. 2006; 29: 225-231.
33. Overman MJ, Varadhachary GR, Kopetz S, et al. Phase II study of capecitabine and oxaliplatin for advanced adenocarcinoma of the small bowel and ampulla of Vater. J Clin Oncol. 2009; 27: 2598-2603.